The University of Kansas Cancer Center-South — Kansas City, Missouri

The University of Kansas Cancer Center-South is a clinical research site located in Kansas City, Missouri, United States 64131.

Crixeo Clinical Trials Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

The University of Kansas Cancer Center-South has participated in 70 clinical trials with 34 currently active.

Therapeutic areas: Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Kansas City

Browse all research sites in Missouri · View every site in Kansas City

• Children's Mercy Hospital & Clinics
• Children's Mercy Hospital
• Children's Mercy Hospital - Department of Nephrology
• University of Kansas Medical Center
• University Of Kansas Cancer Center
• University of Missouri - Kansas City / The Children's Mercy Hospital
• University Health Truman Medical Center
• Children's Mercy Hospital/ID# 200221
• Saint Luke's Hospital/Marion Bloch Neuroscience Institute Dept of Regulatory
• VA Medical Center
• Saint Luke's Hospital of Kansas City Mid America
• Section of Pediatric Nephrology, Children's Mercy Hospitals and Clinics

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Kansas Cancer Center-South?

The University of Kansas Cancer Center-South has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Kansas Cancer Center-South conducted?

The University of Kansas Cancer Center-South has 70 clinical trials on record, with 34 currently active. Their work covers Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Is The University of Kansas Cancer Center-South accredited by Crixeo Clinical Trials?

The University of Kansas Cancer Center-South has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Kansas Cancer Center-South?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.